Pepti Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.9/10
Best for: the lowest all-in monthly price we have verified on compounded semaglutide, labs included
Price is where Pepti scores best in our breakdown.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Included
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Pepti is a Delaware-registered telehealth platform selling doctor-prescribed compounded peptides and GLP-1s across 36 states. Injectable semaglutide is $99 a month all-in and tirzepatide $199, each covering medication, physician review, baseline labs, refill management and shipping in a single flat price that does not rise with dose. The catalogue runs to more than 120 products across weight loss, hormones and TRT, recovery, cognitive and skin categories, plus at-home bloodwork. Pepti is a platform, not a prescriber, and does not bill insurance.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Pepti
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Pepti at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $99/mo (All-in monthly subscription covering medication, physician care, labs and shipping. A one-time non-subscription vial is $124.)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping · Labs
- Availability
- 36 states
- FDA status
- No FDA warning letter on record
How we scored Pepti
Each dimension is scored algorithmically from Pepti’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
9.1/10At $99/mo, Pepti runs about 41% below the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.9/10Pepti offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.2/10Online intake and platform experience — consult included in the price; 7 platform features disclosed.
Trust & Safety15%
8.6/10Key details fully confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-08-07).
Accessibility10%
7.5/10Pepti is available in 36 states. FSA/HSA cards are accepted.
Support10%
5.7/10Pepti provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Pepti review
Last checked August 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed availability in 36 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
What to expect when you sign up with Pepti
We walked Pepti’s public signup flow in August 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Browse the public catalogue, where every treatment price is shown before any account is created
- 2Start a free assessment answering medical screening questions
- 3An independent licensed physician reviews the intake against set exclusion criteria
- 4If approved, a 503A or 503B compounding pharmacy dispenses and ships free in unbranded, tamper-evident packaging
- 5Ongoing care includes refill management and unlimited messaging with the prescribing physician
- Every price is published openly, including a dedicated cost page per drug comparing against brand-name pricing.
- The assessment is free and you are not charged for medication if a physician does not approve you.
- Product pages carry an explicit disclaimer that compounded medications are not FDA-approved or FDA-cleared.
- A state-availability checker is offered, and each of the 36 covered states has its own page.
- The all-in price is stated to include labs, shipping and physician messaging, with no separate membership fee.
GLP-1 medications Pepti offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides Pepti offers
Beyond GLP-1s, Pepti also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
All-in monthly subscription covering medication, physician care, labs and shipping. A one-time non-subscription vial is $124.
All-in monthly subscription. A one-time non-subscription vial is $249.
Oral semaglutide, priced above the injectable.
Oral tirzepatide, priced above the injectable.
Ready to get started?
Plans and promotions change often — check Pepti's current pricing and active discounts before you decide.
What we like
- At $99/mo all-in, injectable semaglutide is among the cheapest verified prices in our catalogue.
- States plainly that all doses cost one flat monthly price, so titrating up never raises the bill.
- Publishes a page for each of the 36 states it serves, and the page count matches its claim exactly.
- Names the reviewing physician, Dr. Gene Lee MD, and discloses pepti LLC as the Delaware operating entity.
Watch-outs
- The homepage shows an "FDA Cleared" badge beside peptide therapy, though product pages correctly say compounded drugs are not FDA-approved.
- Neither the 503A nor the 503B compounding pharmacy is named, so you cannot check who dispenses.
- The listed address, a Newark Delaware suite, is a shared registered-agent address rather than a clinical office.
- Cash-pay only with no insurance billing, and the oral formulations jump to $249 and $399 a month.
Is Pepti worth it? Our verdict
Pepti positions itself around one thing: the lowest all-in monthly price we have verified on compounded semaglutide, labs included. It runs $99/month, flat across every dose — toward the affordable end of the market. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
Beyond the core GLP-1 program, Pepti leans on Flat price at every dose, Labs included in price, and 36 states, all listed.
How much Pepti actually costs
- Compounded semaglutide — $99/month
- Compounded tirzepatide — $199/month
- Compounded semaglutide — $249/month
- Compounded tirzepatide — $399/month
That puts Pepti below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
For a direct comparison, Sesame Care runs semaglutide and tirzepatide from $59/month — worth pricing against Pepti before you commit.
Medications: what Pepti prescribes
Pepti prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the pair backed by the largest published weight-loss trials. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who Pepti is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Pepti is available in 36 states, and dispenses through an accredited compounding pharmacy. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Pepti earns its place on the shortlist mainly on price: at $99/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where Pepti scores best in our breakdown.
Ready to start with Pepti?
Starting at $99/month. See current pricing and start your free consultation.
Pepti might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider ShedRx.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Pepti review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Pepti's current pricing
Plans start at $99/month. Start your free consultation to check eligibility and today's price.